To further verify the effectiveness of MMP-1 as a salivary biomarker for oral cancer detection, we used this in-house-developed ELISA to analyze levels of MMP-1 in 1160 clinical saliva samples from healthy subjects and patients with OPMD or OSCC. This evidence concerns the gene MMP1 and lip and oral cavity carcinoma.